ANSTO annual report 2001-02
| dc.contributor.author | Australian Nuclear Science and Technology Organisation | en_AU |
| dc.date.accessioned | 2009-10-23 | en_AU |
| dc.date.accessioned | 2010-04-30T04:08:44Z | en_AU |
| dc.date.available | 2009-10-23 | en_AU |
| dc.date.available | 2010-04-30T04:08:44Z | en_AU |
| dc.date.issued | 2002 | en_AU |
| dc.description.abstract | The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. It does so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. This is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, close to Sydney’s central business district. ANSTO has a salaried staff of approximately 850. Its main site is located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district. The LHSTC occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals. | en_AU |
| dc.identifier.govdoc | 5 | en_AU |
| dc.identifier.issn | 1031-6655 | en_AU |
| dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/2079 | en_AU |
| dc.language.iso | en | en_AU |
| dc.publisher | Australian Nuclear Science and Technology Organisation | en_AU |
| dc.relation.ispartofseries | Annual report | en_AU |
| dc.subject | ANSTO | en_AU |
| dc.subject | Progress report | en_AU |
| dc.subject | HIFAR Reactor | en_AU |
| dc.subject | Radiopharmaceuticals | en_AU |
| dc.subject | Australia | en_AU |
| dc.subject | Cyclotrons | en_AU |
| dc.title | ANSTO annual report 2001-02 | en_AU |
| dc.type | External Report | en_AU |